Trial details
Type: Expanded AccessSponsor: Regeneron PharmaceuticalsUpdated: Mar 31, 2026
Eligibility criteria
Not listed
Review clinical trials related to Renal Medullary Carcinoma (RMC). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
Not listed